Dexcom (DXCM) Total Current Liabilities (2010 - 2026)

Dexcom (DXCM) has 17 years of Total Current Liabilities data on file, last reported at $2.2 billion in Q1 2026.

• Quarterly Total Current Liabilities fell 26.78% year-over-year to $2.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 billion (down 26.78% YoY) and the FY2025 annual result came in at $2.1 billion, down 26.93% from the prior year.
• Total Current Liabilities grew to $2.2 billion in Q1 2026 per DXCM's latest filing, from $2.1 billion in the prior quarter.
• Across five years, Total Current Liabilities topped out at $3.3 billion in Q3 2025 and bottomed at $711.4 million in Q1 2022.
• The 5-year median for Total Current Liabilities is $1.8 billion (2022), against an average of $2.0 billion.
• The widest annual swing landed in 2023, when Total Current Liabilities jumped 162.16%; it then dropped 26.93% in 2025.
• Tracing DXCM's Total Current Liabilities over 5 years: stood at $1.8 billion in 2022, then slipped by 15.4% to $1.6 billion in 2023, then surged by 88.43% to $2.9 billion in 2024, then retreated by 26.93% to $2.1 billion in 2025, then climbed by 3.79% to $2.2 billion in 2026.
• Per Business Quant, the three latest DXCM Total Current Liabilities figures stand at $2.2 billion (Q1 2026), $2.1 billion (Q4 2025), and $3.3 billion (Q3 2025).

Peer Comparison